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Abstract
The role of adenosine A2A receptor (A2AR) and striatal-enriched protein tyrosine phosphatase (STEP) interactions in the 
striatal-pallidal GABA neurons was recently discussed in relation to A2AR overexpression and cocaine-induced increases 
of brain adenosine levels. As to phosphorylation, combined activation of A2AR and metabotropic glutamate receptor 5 
(mGluR5) in the striatal-pallidal GABA neurons appears necessary for phosphorylation of the GluA1 unit of the AMPA 
receptor to take place. Robert Yasuda (J Neurochem 152: 270–272, 2020) focused on finding a general mechanism by which 
STEP activation is enhanced by increased A2AR transmission in striatal-pallidal GABA neurons expressing A2AR and 
dopamine D2 receptor. In his Editorial, he summarized in a clear way the significant effects of A2AR activation on STEP in 
the dorsal striatal-pallidal GABA neurons which involves a rise of intracellular levels of calcium causing STEP activation 
through its dephosphorylation. However, the presence of the A2AR in an A2AR-fibroblast growth factor receptor 1 (FGFR1) 
heteroreceptor complex can be required in the dorsal striatal-pallidal GABA neurons for the STEP activation. Furthermore, 
Won et al. (Proc Natl Acad Sci USA 116: 8028–8037, 2019) found in mass spectrometry experiments that the STEP splice 
variant  STEP61 can bind to mGluR5 and inactivate it. In addition, A2AR overexpression can lead to increased formation 
of A2AR-mGluR5 heterocomplexes in ventral striatal-pallidal GABA neurons. It involves enhanced facilitatory allosteric 
interactions leading to increased Gq-mediated mGluR5 signaling activating STEP. The involvement of both A2AR and 
STEP in the actions of cocaine on synaptic downregulation was also demonstrated. The enhancement of mGluR5 protomer 
activity by the A2AR protomer in A2AR-mGluR5 heterocomplexes in the nucleus accumbens shell appears to have a novel 
significant role in STEP mechanisms by both enhancing the activation of STEP and being a target for  STEP61.
Keywords Allosteric receptor–receptor interactions · Adenosine A2A receptor · Cocaine · Striatal-enriched protein tyrosine 
phosphatase · Oligomerization · Phosphorylation
Introduction
In a recent Editorial by Robert Yasuda [1] on striatal-
enriched protein tyrosine phosphatase (STEP) activity in 
central nervous system (CNS), the role of adenosine and 
STEP in modulating synaptic glutamate receptor function 
has been discussed, especially in relation to how STEP 
might be modulated by the adenosine A2A receptor (A2AR) 
activation [2]. Changes induced in striatal synaptic gluta-
mate transmission were modulated by cocaine (10 µM) by 
an increase in adenosine levels and the consequent A2AR 
activation, a mechanism involving the participation of STEP 
[3] and mediating the A2AR agonist-induced reduction in 
cocaine self-administration. The possible involvement of 
A2AR-dopamine (DA) D2R heteroreceptor complex in 
STEP-mediated A2AR agonist-induced reduction in cocaine 
self-administration has also be proposed by R. Yasuda in 
its Editorial [1]. In this heteroreceptor complex, the A2AR 
protomer allosterically inhibits the DA D2R protomer 
 * Dasiel O. Borroto-Escuela 
 dasiel.borroto.escuela@ki.se
 * Kjell Fuxe 
 kjell.fuxe@ki.se
Extended author information available on the last page of the article
1097The coming together of allosteric and phosphorylation mechanisms in the molecular integration…
1 3
signaling in the ventral striatal-pallidal GABA neurons [4, 
5], leading to an inhibition of cocaine self-administration 
[6–8],
The present article aims to continue this original discus-
sion, by focusing on the role that different A2AR heterore-
ceptor complexes might play in mediating STEP activation. 
In particular, the article will shortly illustrate the basic work 
on the neurochemical anatomy of the ventral and dorsal stri-
atal-pallidal GABA neurons [4, 9, 10], and on adenosine 
receptor subtypes with a focus on A2AR, their signaling and 
function along with their heteroreceptor complexes [11, 12]. 
Then, the fundamentals of the STEP and its splice variants 
will be given [13–15], followed by presentation of STEP 
phosphorylation processes induced by activation of A2AR, 
metabotropic glutamate receptor 5 (mGluR5) and D2R.
Of special interest is the demonstration that upon activa-
tion by (S)-3,5-Dihydroxyphenylglycine (DHPG), a potent 
agonist of group I metabotropic glutamate receptors, STEP 
becomes activated in hippocampal slices and produces 
AMPA receptor (AMPAR) endocytosis [16]. The mGluR5 
may therefore be involved in activating STEP. We now also 
propose that the A2AR protomer activation by the A2AR 
agonist in an A2AR-fibroblast growth factor receptor 1 
(FGFR1) heteroreceptor complex [17] can be necessary for 
the STEP activation by A2AR stimulation.
Striatal‑pallidal GABA medium spiny 
neurons [MSNs; also known as spiny 
projection neurons (SPNs)]
The dorsal striatal‑pallidal GABA SPNs
These striatal GABA neurons are located in the caudate 
putamen, which forms the dorsal striatum representing 
a major part of the basal ganglia. These GABA neurons 
project into the external segment of globus pallidus, thus 
inhibiting the activity of pallidal-subthalamic nucleus (STN) 
GABA neurons, which in turn modulate the activity of STN 
glutamate pathway. STN glutamate projections then reach 
and drive the GABA projection neurons of the internal seg-
ment of globus pallidus and pars reticulata of the substantia 
nigra, which modulate the activity of the thalamic glutamate 
projections to the cortical motor regions, thus controlling 
movements [9, 18]. The striatal GABA neurons of this brain 
circuit are known as the indirect striatal projection neurons 
(i.e., striatal indirect pathway), since they connect indirectly 
to the internal segment of the globus pallidus and the sub-
stantia nigra pars reticulata via the external segment of the 
globus pallidus and the STN. About half of SPNs constitutes 
instead the direct pathway, projecting directly to the internal 
segment of the globus pallidus and substantia nigra pars 
reticulata.
Upon activation of the dorsal striatal-pallidal GABA neu-
rons by glutamate synapses via the cortical-striatal gluta-
mate neurons, inhibition of movements will develop through 
the brain circuit described above. In fact, an increased glu-
tamate drive from the subthalamic nucleus will develop, 
leading to activation of the inhibitory GABA neurons of 
the internal segment of the globus pallidus and the substan-
tia nigra pars reticulata projecting into the thalamus. This 
leads to an inhibition of the thalamic glutamate drive to the 
cortical motor regions. As result, movements will become 
reduced due to diminished action selection. Thus, activation 
of the dorsal striatal-pallidal GABA neurons represents the 
activation of a so-called “no-go” pathway [9].
The dorsal striatal-pallidal GABA pathway is enriched 
primarily in D2R and A2AR [9, 19]. Upon activation of 
the D2R located on the somato-dendritic regions of this 
pathway, the indirect SPN intrinsic excitability is inhibited 
through postsynaptic effects on ion channels, thus bringing 
down the impact of glutamate transmission and enhancing 
long-term synaptic depression development [18]. Thus, the 
D2R can upon agonist activation effectively reduce the acti-
vation of the indirect SPN and thereby improve movements, 
as also demonstrated by the evidence that D2R agonists pos-
sess antiparkinsonian actions [20].
The ventral striatal‑pallidal GABA SPNs
The main part of the ventral striatum is the nucleus accum-
bens, which is part of the basal ganglia and is innervated 
by the meso-limbic DA reward neurons [4, 6]. The nucleus 
accumbens connects with the ventral pallidum; the ventral 
striatal-ventral pallidum GABA SPNs originate from the 
nucleus accumbens shell and core. The ventral pallidum 
GABA projections then innerve the glutamate neurons of 
the medial dorsal thalamic nucleus which projects into the 
prefrontal cortex [4]. The analysis indicates that the ventral 
striatal-pallidal GABA SPNs are anti-reward and aversion 
neurons [6, 21, 22]. They are enriched in D2R and A2AR 
and the rewarding actions of cocaine can involve inhibition 
of the DA transporter with increased extracellular DA levels 
activating the D2R on the ventral striatal-pallidal GABA 
SPNs. These events lead to inhibition in activity of this anti-
reward pathway which will enhance cocaine reward.
Adenosine A2AR and their location 
and functional role in the dorsal and ventral 
striatum
Adenosine is an endogenous widespread modulator released 
in the CNS and periphery. Adenosine effects are mediated by 
four different subtypes of adenosine receptors: A1R, A2AR, 
A2BR and A3R [12]. All of them are high affinity receptors 
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except the A2BR which are of low affinity. The A2ARs are 
Gs or Golf coupled receptors that operate via adenylate 
cyclase/protein kinase (AC/PKA) intracellular pathways 
involving activation of extracellular signal-regulated kinases 
(ERK1/2), protein kinase B (AKT) and cAMP response 
element-binding protein (CREB) through phosphorylation 
including also DA and cAMP-regulated phosphoprotein 
(DARPP-32)[23].
The A2ARs are highly expressed in the dorsal and ventral 
striatum and exist in reduced but significant densities e.g., 
in the hippocampus and the cerebral cortical regions [12]. 
The A2AR is expressed both in neurons and in all types of 
astroglia. This adenosine receptor subtype has multiple func-
tions in the CNS linked to movements, cocaine reward and 
addiction, excitotoxicity, learning and memory [12].
Adenosine heteroreceptor complexes 
in the brain, especially in the dorsal 
and ventral striatum
The concept of direct receptor–receptor interactions in 
the plasma membrane between different types of recep-
tors (especially G protein-coupled receptors; GPCRs) was 
introduced in the beginning of the 1980s and, in 1993, 
the concept was developed that they were made possible 
through the formation of receptor heterodimers or higher 
order heteromers [24, 25]. Subsequently, the term heterore-
ceptor complexes was introduced since it was not possible to 
know the composition and stoichiometry of the heteromers 
in tissues like the brain also involving the presence of vari-
ous types of adapter proteins interacting with the GPCRs. 
Large numbers of homo- and heteroreceptor complexes have 
now been described in the brain [25]. They represent a new 
general integrative mechanism for multiple signals in the 
brain and other organs and, by allosteric receptor–recep-
tor interactions, they modulate recognition, signaling and/
or trafficking of the participating receptor protomers. Thus, 
in addition to the well-known phosphorylation mechanisms 
[26, 27], also allosteric mechanisms play a significant role 
in the heteroreceptor complexes. Receptor pharmacology 
and function become more diverse and selective through 
the allosteric receptor–receptor interactions in the hetero-
receptor complexes.
A2AR isoreceptor complexes
A2AR forms isoreceptor complexes when interacting with 
other types of adenosine receptor like A1R, A2BR and 
A3R [28–30], as demonstrated using proximity ligation 
assay [31–33] and BRET techniques [34]. A2AR can also 
interact with other A2ARs which leads to formation of 
A2AR-A2AR homodimers [34]. It is of substantial interest 
that inter alia the A2AR protomer can reduce the A1R 
protomer inhibitory signaling in the A1R-A2AR isorecep-
tor complex and the A2BR protomer can block the A2AR 
recognition and signaling in the A2AR-A2BR isoreceptor 
complex. It remains to be demonstrated which of them 
exist in the striatal-pallidal GABA neuron.
A2AR heteroreceptor complexes
The most well-known A2AR heteroreceptor complex is 
the A2AR-D2R heteroreceptor complex demonstrated with 
e.g., proximity ligation assay and BRET/FRET methods 
[33, 35], and found in highest densities in the dorsal and 
ventral striatal-pallidal GABA projection neurons [31, 
32]. These heteroreceptor complexes likely also exist in 
the cholinergic striatal interneurons where the A2AR and 
D2R coexist. Antagonistic allosteric receptor–receptor 
interactions take place in these A2AR-D2R heterocom-
plexes through which agonist activation of the A2AR 
protomer produces a strong reduction of the affinity for 
the ligands on the high affinity D2R agonist binding of the 
D2R protomer. Furthermore, the A2AR agonist induces 
a strong reduction of the Gi/o-mediated signaling of the 
D2R signaling [35, 36]. The β-arrestin is instead recruited 
to the D2R protomer and takes over its signaling [37]. 
A structural model of the A2AR-D2R heterodimer was 
achieved with a transmembrane interface involving trans-
membrane IV/V domains [7, 34, 38]. These heteroreceptor 
complexes exist both in the ventral and dorsal striatal-
pallidal GABA neurons, as detailed below.
Dorsal striatal‑pallidal GABA neurons
It should be noted that an A2AR agonist blocks the D2R 
induced long-term depression with a return of long-term 
potentiation in the dorsal striatum. It likely involves 
antagonistic allosteric A2AR-D2R interaction in the dor-
sal striatal-pallidal GABA neurons [5]. The A2AR-D2R 
heteroreceptor complexes in these neurons are implicated 
in Parkinson’s disease and its treatment. Early on in this 
disease the motor dysfunction is effectively counteracted 
by levodopa treatment. However, with time, through the 
continued degeneration of especially the nigro-striatal DA 
neurons and continued chronic treatment with dopamin-
ergic drugs, a reorganization of the A2AR-D2R heterore-
ceptor complexes likely develops. This can lead to reduc-
tion of the therapeutic effects of DA agonists involving 
enhanced pathology of the DA neurons and to augmented 
A2AR-mediated inhibition of the D2R signaling. There-
fore, motor deficits increase with wearing off of the thera-
peutic effects of dopaminergic drugs.
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Ventral striatal‑pallidal GABA neurons
The nerve cell bodies of these projection neurons mediat-
ing anti-reward are mainly located in the nucleus accum-
bens and innervate the ventral pallidum. They are enriched 
in A2AR and D2R forming A2AR-D2R heteroreceptor 
complexes that bring down cocaine reward, as demon-
strated in cocaine self-administration [6, 8, 21]. In cocaine 
use disorder (cocaine addiction), it was proposed that a 
permanent brake can develop on D2R protomer affinity 
and signaling in A2AR-D2R-Sigma1 receptor (Sigma1R) 
complexes formed upon chronic use of cocaine [6, 8, 39]. 
These pathological complexes can form a long-term mem-
ory involving a marked and long-lasting brake on D2R 
protomer function in the anti-reward GABA neurons, thus 
causing cocaine addiction. These heteroreceptor com-
plexes may become new targets for treatment of cocaine 
addiction, involving receptor interface, interfering peptides 
and hetero-bivalent compounds that can remove the brake 
on D2R protomer signaling in the A2AR-D2R-Sigma1R 
complexes. In this way, the D2R protomer can improve 
its function and to some degree reduce the activity in the 
ventral striatal-pallidal GABA anti-reward neurons which 
will to a certain degree assist in returning cocaine reward.
A2AR‑mGluR5 and A2A‑D2R‑mGluR5 heteroreceptor 
complexes
These heteroreceptor complexes likely exist both in the 
dorsal and ventral striatal-pallidal GABA neurons [40–42]. 
The A2AR and mGluR5 protomers synergize the effects 
of each other and to inhibit the D2R protomer signaling in 
this trimeric complex, leading to inhibition of the activ-
ity in the motor circuits regulated by the dorsal striatal-
pallidal GABA neurons [11]. In the ventral striatal-pallidal 
GABA anti-reward neurons, these two receptor protom-
ers again appear to enhance the signaling of each other 
and their downregulation of the D2R protomer signaling 
located in the same trimeric complex [41] leading to fur-
ther inhibition of the inhibitory D2R protomer signaling. 
The activity of the GABA anti-reward neurons should, 
therefore, become further increased and cocaine reward 
further reduced.
The A2AR-D2R-mGluR5 heteroreceptor complexes, 
discussed above, in the ventral striatal-pallidal GABA 
anti-reward neurons are also of high relevance for under-
standing schizophrenia in view of the DA hypothesis of 
this disease [4, 43, 44]. In schizophrenic individuals, the 
A2AR and mGluR5 protomers can synergize to inhibit the 
overactivity of the D2R protomer signaling in the nucleus 
accumbens, which represents the major region of the ven-
tral striatum.
A2AR‑FGFR heteroreceptor complexes
In 2008, it was found by Flajolet et al. [17] that the FGFR1 
can form a heteroreceptor complex with the A2AR in the 
dorsal striatal-pallidal GABA neurons using a yeast two-
hybrid analysis. It enhanced structural and functional syn-
aptic plasticity. Coactivation of the two receptors produced 
synergistic enhancement of spine and neurite densities and 
cortical-striatal long-term potentiation developed in the glu-
tamate synapses on the striatal-pallidal GABA neurons.
As to the molecular mechanism, the authors proposed 
that the coactivation of the FGFR1 and A2AR protomers 
led to a synergistic in the ERK1/2/mitogen-activated protein 
kinase (MAPK) intracellular pathway [17]. In the case of 
the A2AR, the ERK1/2/MAPK pathway became increased 
through the AC/PKA/exchange protein directly activated 
by cAMP (EPAC)/Raf activation of MAPK. Instead, the 
FGFR1 became linked to the ERK1/2/MAPK pathway via 
the growth factor receptor-bound protein 2 (Grb2)/Ras/Raf-
cascade. The heteromerization was regarded as necessary 
to confine the two receptor protomers to the same micro-
environment that would allow the combined phosphorylation 
of a signaling molecule downstream. It should be noted that 
the stimulation of the ERK1/2/MAPK pathway was regarded 
as being controlled only by protein kinase phosphorylation 
actions. No indications for allosteric events in the heterore-
ceptor complex were obtained.
However, it was considered that protein phosphatases can 
have a role through dephosphorylation of inhibitory sites 
which would allow an optimal conformation of ERK1/2. 
Early on, it was in fact found that a protein phosphatase 
cascade can make possible converging glutamate and DA 
signals to stimulate striatal ERK1/2 [27]. It should be noted 
that a structural model of the A2AR-D2R heterodimer was 
achieved with a transmembrane interface involving trans-
membrane IV/V domains [7, 34, 38].
This early work opened up the possibility that phospho-
rylation and allosteric mechanisms can operate in parallel 
to integrate multiple transmitter and modulator signals in 
heteroreceptor complexes.
On the role of STEP, a striatal‑enriched 
protein tyrosine phosphatase
STEP targets a widespread network of synaptic and extra-
synaptic brain proteins and is specific to the brain [45]. 
There exist a number of splice variants,  STEP61,  STEP46, 
 STEP38, and  STEP20. They differ in terms of distribution in 
the brain, membrane association and length of protein. It 
should be noticed that only one of them is enriched in the 
striatum, namely  STEP46. The long form  STEP61 is pre-
sent all over the brain and is expressed in high densities in 
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the hippocampus and the cortex cerebri [15]. The  STEP61 
interactome is extensive and involves by 8% ion channels, 
receptors and transporters, by 20% vesicle trafficking pro-
teins, by 7% scaffolding proteins, by 3% ubiquitin enzyme 
proteins, by 16% kinases and phosphatases, by 4% cell 
adhesion proteins, by 8% ATP synthase and ATPase, by 
4% GPCR signaling proteins and by 30% cytoskeleton or-
associated and motor proteins [13]. They are all regulated 
by STEP through dephosphorylation. It becomes clear that 
there exist multiple targets through which  STEP61 can reg-
ulate synaptic and volume transmission.
It is of interest that  STEP61 exists in high densities in 
the synaptic membranes but are diminished in the post-
synaptic density [13]. It was suggested that  STEP61 mainly 
may produce effects on its biological substrates in the 
extra-synaptic regions. These findings are of relevance 
since it indicates that also extra-synaptic receptors and 
their complexes mediating volume transmission [46] are 
regulated by  STEP61.
As previously described,  STEP61 represents the full-
length protein. It has five different components, the pro-
line-rich domain, the transmembrane domain, the kinase-
interacting motif (KIM), the kinase-specificity sequence 
domain (KIS) and the protein tyrosine phosphatase domain 
(PTP) [15]. The four splice variants listed originate from 
a single gene but the  STEP38 and  STEP20 lack the PTP 
domain. Their function is, therefore, not clear since they 
miss the catalytic activity. It may be that these short splice 
STEP variants have the ability to compete with the long-
splice STEP variants for the same STEP substrate-bind-
ing sites. There also exists another short STEP, namely 
 STEP33, that is formed by truncation of  STEP61 caused by 
calpain induced cleavage of  STEP61 [15].
The major activation of STEP takes place through 
activated calcineurin turning on protein phosphatase 1, 
producing a dephosphorylation of STEP which causes 
activation of STEP [1]. As to removal of STEP, it was 
demonstrated that ubiquitination of STEP is produced by 
synaptic activation causing its degradation. This process is 
enhanced by the binding of STEP to postsynaptic density 
protein 95 (PSD-95). Furthermore, the PSD-95 stabilizes 
N-methyl-D-aspartate receptor (NMDAR) which improves 
its synaptic strength [47].
Furthermore, STEP differentially control NMDARs 
and AMPA receptors (AMPAR). In view of the ability of 
STEP to control many types of synaptic and extra-synaptic 
proteins, there is agreement that dysregulation of STEP 
can be a significant factor in contributing to synaptic and 
extra-synaptic plasticity. STEP can be a relevant factor in 
neurodegenerative diseases like Parkinson’s disease and 
there is support for the view that inhibition of STEP can be 
used in the treatment of neurocognitive disease [15, 48].
Phosphorylation events in striatal‑pallidal 
GABA neurons mediated via A2AR, mGluR5 
and D2R
Svenningsson and colleagues in 1998 [49] found that A2ARs 
upon activation stimulate cyclic AMP-dependent phosphoryla-
tion of DARPP-32 in striatal-pallidal GABA neurons, leading 
to a conversion of this inactive molecule into a highly potent 
protein phosphatase 1 (PP1) inhibitor [50]. The DARPP-
32/PP1 interaction regulates the strength of the AMPA and 
NMDA glutamate receptor signaling with their dephospho-
rylation reducing their currents over the ion channels [51]. It 
is of interest that the A2AR-induced activation of the PKA-
DARPP-32 signaling leads to increased phosphorylation of 
the GluA1 unit of the AMPARs in the striatal-pallidal GABA 
neurons which is enhanced by a mGlu5R agonist [52]. It may 
develop through the existence of A2AR-mGlu5R and A2AR-
mGluR5-D2R heteroreceptor complexes in the striatal-pallidal 
GABA neurons leading to enhancement of mGluR5 protomer 
signaling via facilitatory A2AR-mGluR5 allosteric interac-
tions in these complexes [40, 53].
It should be noted that upon interference with the site for 
PKA phosphorylation at DARPP-32, the effects of the group 
1 mGluR5 agonist (R, S)-3,5-dihydroxyphenylglycin (DHPG) 
on GluA1 phosphorylation was blocked [52]. Thus, there 
appears to exist a demand of increased phosphatase inhibi-
tion over the PKA-DARPP-32 pathway for enhanced phos-
phorylation of the GluA1 subunit of the AMPAR to develop. 
The demonstration that adenosine deaminase, which catalyzes 
the irreversible deamination of adenosine, blocked the Ser 
845 phosphorylation of GluA1 by DHPG also shows the need 
for combined activation of A2AR and mGluR5 for the phos-
phorylation of GluA1 to take place [52]. In addition, it was 
found that combined agonist activation of mGluR5 and A2AR 
protomers appeared to enhance their allosteric inhibition of the 
D2R protomer that further reduces the inhibitory signaling of 
the D2R protomer [41, 53].
In the dorsal striatum, these events will lead to enhance-
ment of the inhibition of the motor drive since the dorsal stri-
atal-pallidal GABA neurons mediates inhibition of movements 
[11, 18, 54]. In line with these results, it was found early on 
that D2R antagonists enhance the GluA1 AMPAR phospho-
rylation related to the removal of the D2R mediated inhibition 
of the PKA/DARPP-32 signaling pathway [13].
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Understanding the link between the A2AR 
modulation of STEP activity and the A2AR 
protomer‑induced enhancement of mGluR5 
protomer signaling in A2AR‑mGluR5 
andA2AR‑D2R‑mGluR5 hetero complexes 
of the striatal‑pallidal GABA neurons
In its Editorial [1], Robert Yasuda focused on having a 
general mechanism by which STEP is modulated by A2AR 
upon its activation in neurons expressing A2AR and D2R, 
which can include also neuroblastoma cell lines, known 
to express these receptors [55]. The modulation of STEP 
by A2AR involved a calcineurin/PP1 pathway which was 
calcium dependent [3]. Robert Yasuda in his abstract [1] 
summarizes in a clear way the significant effects of A2AR 
activation which involves a rise of intracellular levels of 
calcium, a STEP activation through dephosphorylation and 
an inhibition of synaptic signaling in ionotropic glutamate 
receptors by tyrosine dephosphorylation of these recep-
tors. It leads to their removal from the plasma membrane 
through endocytosis and degradation by lysosomes.
Recently, in mass spectrometry experiments, it was 
found that the STEP splice variant  STEP61 can bind to a 
large network of synaptic proteins [13]. Of high relevance 
for the current perspective article is that the  STEP61 inter-
actome involves not only GluN2B, GluN1 but also GluA2, 
GluA3 subunits of the NMDAR and AMPAR, respectively, 
and especially mGluR5 but not GluA1 [13]. Thus, the 
synergistic A2AR-mGluR5 receptor–receptor interac-
tions [40] enhancing their signaling become of substan-
tial interest not only because the Gq signaling of mGluR5 
produces increases of intracellular calcium levels leading 
to activation of STEP (Domenici et al., 2021), but also 
because there is a direct STEP feedback onto the mGluR5 
(Fig. 1). This can produce a dephosphorylation of its tyros-
ine residues with hypofunction of mGluR5 regarding e.g., 
interplay between GluN and mGluR5, evoked ERK1/2 
signaling and the allosteric A2AR-mGluR5 interactions 
[56–58]. It will also be of substantial interest to study how 
the binding of  STEP61 and other splice variants of STEP 
through their dephosphorylation actions can modulate the 
striatal A2AR-mGluR5 and A2AR-D2R-mGluR5 hetero-
receptor complexes. It should be noticed that the work 
of Won et al. [13] was performed on hippocampus and 
neocortex where  STEP61 is by far the dominating form.
The most frequent AMPAR is built up of a GluA1/2 het-
eromer [13]. In view of the absence of  STEP61 binding to the 
Fig. 1  Cocaine, A2AR and STEP interactions activating STEP in the 
ventral striatum can be increased through enhanced allosteric recep-
tor-receptor interactions in A2AR-mGluR5 heteroreceptor complexes 
in the ventral striatal-pallidal GABA neurons with A2AR protomer 
(orange color) activation increasing mGluR5 protomer (green color) 
signaling. The Gq activation results in increased PLC beta activity 
leading to a rise of intracellular calcium levels via improved IP3 lev-
els and increased activation of calcineurin. Its phosphatase activity in 
turn activates PP1 which then via dephosphorylation activates STEP. 
Activated STEP bound to AMPAR and NMDAR can then inactivate 
these excitatory synaptic glutamate receptors via dephosphoryla-
tion followed by their internalization. A dynamic synaptic downreg-
ulation develops. To the left part of the figure, it is shown that this 
dynamic process can be counteracted by PP1induced activation of 
STEP bound to mGluR5 leading to its inactivation. The reduction of 
the mGluR5 signaling can then reduce the process of activated STEP 
binding to AMPAR and NMDAR with a return of excitatory synaptic 
signaling
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GluA1 [13], the direct  STEP61 modulation of this AMPAR 
may only involve tyrosine dephosphorylation of the GluA2 
unit but with a potential for allosteric modulation by the 
dephosphorylated GluA2 of the GluA1 subunit. However, 
it should be considered that other splice variants of STEP 
may bind to GluA1.
It is of special interest that in transgenic rats overex-
pressing neuronal A2AR in the brain under the regulation 
of a neural-specific enolase promotor [59, 60], markedly 
enhanced increases developed in protein tyrosine phos-
phatases and especially in STEP compared to control rats 
taking place inter alia in the striatum [2]. This increase 
appeared to be maximal since an A2AR agonist failed to 
increase it further, but the increase was blocked by an A2AR 
antagonist. The signaling pathway may involve an A2AR-
mediated increase in intracellular calcium levels that likely 
involves the A2AR-mGluR5 heteroreceptor complex with 
A2AR-induced enhancement of Gq signaling of the mGluR5 
increasing phospholipase C (PLC) activity and intracellular 
calcium levels. This leads to activation of calcineurin which 
via PP1 can activate STEP through its dephosphorylation [2] 
(Fig. 1). This produces synaptic depression through dephos-
phorylation of critical tyrosine phosphates, located on the 
C terminal parts of NMDARs and AMPARs which leads 
to a differential regulation of NMDAR and AMPAR inter-
nalization [1, 13]. Inhibition of the function of the ERK1/2 
signaling pathway also takes place [1]. It was concluded that 
 STEP61 has the power of being a key regulator of synaptic 
glutamate receptors through dephosphorylation, enhancing 
internalization of AMPAR and NMDAR in extra-synaptic 
regions [13].
It should be considered that these events can take 
place in the same neuron of the A2AR, mGluR5 and D2R 
enriched striatal-pallidal GABA pathway that also possess 
the A2AR-D2R heteroreceptor complexes in balance with 
A2AR-mGluR5 and A2AR-D2R-mGluR5 heterorecep-
tor complexes and the corresponding homoreceptor com-
plexes [8, 11, 40, 41]. A2AR activation puts a brake on D2R 
protomer recognition and signaling but enhances mGluR5 
signaling and their facilitatory allosteric interactions leading 
to enhanced inhibition of D2R function [55] that is known 
to inhibit this pathway [18, 54]. This marked inhibition of 
D2R signaling produces a substantial loss of inhibition of 
the striatal-pallidal GABA neurons leading to overactivity 
that in its dorsal component produces inhibition of move-
ments due to the increased firing of this pathway [18, 54]. In 
contrast, a strong coupling of A2AR/mGluR5 signaling of 
these neurons to STEP activation results in synaptic depres-
sion of this pathway. It is due to marked loss of synaptic 
AMPA and NMDA glutamate receptor function through 
dephosphorylation [1] with return of motor activity since 
the synaptic glutamate receptor drive is no longer in opera-
tion at this time in this pathway [1].
The increased strength of STEP activation upon over-
expression of neuronal A2AR in brain regions, including 
the striatum, of a transgenic rat strain can be explained by 
enhanced production of other types of A2AR complexes 
like A2A homoreceptor complexes built up of two or more 
A2AR protomers and A2AR-D2R heteroreceptor com-
plexes with a stoichiometry dominated by A2AR protom-
ers. As a result, high activity A2AR homomers with a lack 
of inhibitory allosteric inputs from the D2R protomer can 
be formed. However, we favor the impact of enhanced for-
mation of A2AR-mGluR5 heteroreceptor complexes that 
can develop with increases in signaling and coupling of 
the mGluR5 protomer to Gq linked to producing activation 
of PLC leading to STEP activation [1, 2]. Novel types of 
adapter proteins within the A2AR-mGluR5 heteroreceptor 
complexes may also participate and enhance the mGluR5 
protomer signaling.
Such events may help explain the markedly increased 
ability of overexpressed A2AR to strongly activate STEP, 
namely through enhanced mGluR5 signaling activating 
STEP leading to marked dephosphorylation by STEP of syn-
aptic glutamate receptors followed by endocytosis in extra-
synaptic domains. Thus, signs of synaptic glutamate depres-
sion can develop due to a reduction of synaptic expression of 
excitatory NMDAR and AMPAR with their currents mediat-
ing the excitatory synaptic glutamate transmission in which 
the dephosphorylation of mGluR5 by STEP can also play a 
relevant role [1, 2, 13].
Cocaine modulation of A2A‑homo‑ 
and heteroreceptor complexes and their 
link to STEP in the ventral and dorsal 
striatal‑pallidal GABA neurons
Cocaine was early on shown to interact directly with the 
Sigma1R [61, 62] and the Sigma1R agonist OSU-6162 
enhanced the antagonistic A2A-D2R receptor–receptor 
interactions in cocaine self-administration [8, 39]. A2AR 
agonists and Sigma1R agonists appear to synergize in their 
inhibition of D2R protomer signaling leading to increased 
firing in the ventral striatal-pallidal anti-reward pathways, 
strongly contributing to inhibition of cocaine reward and 
cocaine seeking [6, 21].
As pointed out by Robert Yasuda [1], it is of substantial 
interest that disruption of the A2AR-D2R heteroreceptor 
complex in the nucleus accumbens fully counteracts the 
A2AR agonist inhibition of cocaine self-administration 
[7]. Thus, this heteroreceptor complex is required for the 
ability of A2AR agonist to inhibit cocaine self-administra-
tion, which is mediated through the inhibition of the D2R 
protomer recognition and signaling [6, 21]
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The differential role of the A2AR in the dorsal versus 
ventral striatum will be discussed with regard to STEP activ-
ity. The significant work of Puighermanal et al. [10] should 
again be considered. They found highly interesting func-
tional and molecular heterogeneities among D2R-positive 
neuronal populations along the dorsal ventral axis in the 
striatum, which could be linked to specific motor behaviors 
like digging behavior and amphetamine-mediated hyperlo-
comotion [10]. The existence of D2R populations within the 
dorsal and ventral striatal-pallidal GABA neurons with a 
distinct pattern of dynamic heteroreceptor complexes involv-
ing inter alia different types of A2AR heteroreceptor com-
plexes, could contribute to these molecular heterogeneities 
and help define subgroups of D2R-positive striatal neurons 
with distinct functions.
Dorsal striatum
In agreement with Robert Yasuda opinion [1], it is of high 
interest that cocaine can reduce the excitatory postsynaptic 
currents mediated by AMPAR and NMDAR in dorsal stria-
tum [3]. The ion currents were counteracted by an A2AR 
antagonist and a trapping mutant of the STEP substrate. 
Therefore, the A2A receptor activation appears to modulate 
the activity of the STEP in neuronal cells [14]. Thus, the 
results indicated the involvement of both A2AR and STEP in 
the actions of cocaine leading to synaptic glutamate receptor 
downregulation.
Other results in the dorsal striatum on the effects of 
cocaine self-administration on the A2AR-D2R and A2AR-
mGluR5 heteroreceptor complexes [8] would be compatible 
with the results above in the dorsal striatum [3]. Thus, there 
was a trend for a reduction of the density of the A2AR-D2R 
and a non-significant reduction in the density of the A2AR-
mGluR5 heteroreceptor complexes in the dorsal striatum 
following cocaine self-administration. Furthermore, cocaine 
self-administration induced a significant reduction in the 
density of D2R-Sigma1R heteroreceptor complexes in the 
dorsal striatum [8]. The trends for reductions in the density 
of both the A2AR-D2R and A2AR-mGluR5 hetero com-
plexes opened the possibility that an increased number of 
A2ARs became free to bind to other A2AR, thus increasing 
the density of A2AR-A2AR homoreceptor complexes. Such 
types of increases in A2AR homoreceptor complexes and 
A2AR monomers in the dorsal striatum may then contribute 
to the demonstrated A2AR-induced activation of STEP [3].
As to the mechanism for the activation by the A2AR of 
STEP in the dorsal striatum, it is suggested that its actions 
can involve and become enhanced by its participation in 
A2AR-FGFR1 heteroreceptor complexes in this region [17] 
(Fig. 1). Thus, coactivation of these two receptor protomers, 
but not their single activation, resulted in a strong increase in 
the activity of the MAPK-ERK1/2 signaling pathway [17]. 
This can in part be mediated by positive allosteric receptor-
receptor interactions in these A2AR-FGFR1 heterorecep-
tor complexes. Co-stimulation also led to cortical-striatal 
long-term potentiation in the dorsal striatal-pallidal GABA 
neurons and to marked structural changes in e.g., neurite 
outgrowth. A marked phosphorylation of ERK1/2 developed 
which was rapid and long-lasting.
Furthermore, cocaine produced ERK1/2 activation in 
the striatum, an action which was counteracted by point 
mutation at Thr-34 in DARPP-32. This protein is known 
to mediate inhibition of PP1 and to be activated by A2AR-
PKA signaling in the striatal-pallidal GABA neurons [27]. 
DARPP-32 regulation can take place both at the ERK1/2 and 
STEP level. However, DARPP-32 appeared to control STEP 
activation in a negative way [27]. Upon phosphorylation by 
PKA, DARPP-32 inhibited the PP1 activity and phosphoryl-
ated STEP (p-STEP) was not dephosphorylated and thus not 
activated. However, the activated A2AR protomer can have 
enhanced, via an allosteric mechanism, the FGFR1 protomer 
signaling in the A2AR-FGFR1 heteroreceptor complex in 
the dorsal striatum. Activated FGFR1 can then accumu-
late in the nucleus and interact with the transcriptional co-
activator CREB-binding protein leading to gene activation 
(Fig. 1) [63]. Consequently, a new panorama of proteins can 
be formed that can have protein phosphatase activity and 
replace the role of PP1 in activating p-STEP. Alternatively, 
the protein can have stimulatory effects on PP1 instead of 
inhibitory actions as exerted by P-Thr -DARPP-32. Future 
work in the dorsal striatum should test this mechanism as a 
way for A2AR to increase STEP activity.
Ventral striatum
As already discussed, cocaine was early on shown to act 
directly with the Sigma1R [61, 62]. It is important to note 
that cocaine administration selectively increased Sigma1R 
in the ventral striatum, but not in the dorsal striatum [64]. 
A2AR agonists and Sigma1R agonists appear to synergize 
in their inhibition of D2R protomer signaling leading to 
increased firing in the ventral striatal-pallidal anti-reward 
pathways, strongly contributing to inhibition of cocaine 
reward and cocaine seeking [6, 21]. Thus, A2AR-D2R-
Sigma1R heteroreceptor complexes likely are formed in the 
nucleus accumbens shell, but not in the dorsal striatum, upon 
cocaine self-administration [8].
In fact, in the work of Borroto-Escuela et al. [8] studying 
the effects of cocaine self-administration on the A2AR-D2R 
and A2AR-mGluR5 heteroreceptor complexes in the nucleus 
accumbens versus the dorsal striatum, marked differences 
were observed in their responses to cocaine self-adminis-
tration. In marked contrast to dorsal striatum, a significant 
increase of the A2AR-D2R complexes and a trend for an 
increase of the A2AR-mGluR5 complexes were observed 
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in the nucleus accumbens shell. These results indicated 
that in this part of the nucleus accumbens the balance of 
the density of A2AR heteroreceptor complexes with the 
density of the A2AR-A2AR homoreceptor complexes had 
switched towards a dominance versus the A2AR heterore-
ceptor complexes. Thus, upon cocaine self-administration 
a reduced density of A2AR homomers and A2AR mono-
mers should exist. A possible STEP activation can in this 
case not be explained by an increase in the density of A2AR 
homomers-monomers.
Should a STEP activation develop in the nucleus accum-
bens shell upon cocaine self-administration, it may instead 
be related to the trend for an increase in the A2AR-mGluR 
heteroreceptor complexes [8]. In addition, it is known that 
these two receptor protomers allosterically enhance the 
effects of each other upon coactivation via allosteric recep-
tor-receptor interactions [40]. Thus, allosteric enhancement 
of the mGluR5 signaling through activation of the A2AR 
protomers can take place. In this way, the Gq signaling of 
the mGluR5 protomer will become enhanced leading to 
increased intracellular levels of calcium that via calcineurin/
PP1 activation can activate STEP.
This proposal is in line with the significant work of Won 
et al. [13] demonstrating that following  STEP61 overex-
pression and activation, the phosphatase can directly bind 
to NMDARs and indirectly to AMPARs via transmem-
brane regulatory proteins enhancing their internalization 
at extra-synaptic sites which may be true also for mGluR5 
[13]. Thus, at least this splice variant of STEP can bind to 
mGluR5 and dephosphorylate its tyrosine residues leading 
to reduction of its activation with negative consequences for 
the phosphorylation of AMPAR and NMDAR [52].
These results suggested the existence of a highly dynamic 
balance between the activity of A2AR-mGluR5 heterorecep-
tor complexes and the activity of STEP in the ventral but not 
dorsal striatal-pallidal GABA neurons which increase and 
reduce glutamate synaptic function, respectively. Accord-
ing to the results above, the mGluR5 protomer in A2AR-
mGluR5 heteroreceptor complexes seems to have an espe-
cially significant role by both enhancing the activation of 
STEP and being a target for STEP producing a downregula-
tion of mGluR5 in the nucleus accumbens shell. mGluR5 
should contribute to a dynamic up- and downregulation 
of synaptic NMDAR (GluN2B and GluN1) and AMPAR 
(GluA2 and GluA3), which may be crucial for the dynamic 
regulation of the brain networks and their function, includ-
ing learning and memory.
However, it is a complex regulation that can differ from 
one brain region to another one like dorsal striatum ver-
sus ventral striatum. The results indicated [8] that in the 
nucleus accumbens shell the A2AR-mGluR5 heterore-
ceptor complexes can have a significant role in cocaine 
self-administration involving activation of STEP function 
through A2AR protomer-induced enhancement which can 
involve of mGluR5 protomer signaling. This mechanism is 
different from the one in dorsal striatum where Chiodi et al. 
[3] demonstrated for the first time that A2AR activation 
can increase STEP function. As discussed, in this region 
the mechanism can be the activation of the A2AR protomer 
in the A2AR-FGFR1 heteroreceptor complex in the dorsal 
striatum (Fig. 2).
Conclusions
Recent works have demonstrated the existence of significant 
interactions between cocaine, A2AR, and STEP involving 
A2AR overexpression and cocaine actions in the dorsal stria-
tum [1–3]. The mechanism for STEP activation can involve 
the activation of the A2AR protomer in an A2AR-FGFR1 
heteroreceptor complex in the dorsal striatum with allosteric 
enhancement also of the FGFR1 protomer signaling. The 
work of Won et al. [13] has also shown that mGluR5 can be 
a target for STEP. It has previously not been discussed how 
mGluR5 can contribute to understanding cocaine, A2AR 
and STEP interactions in the ventral striatal-pallidal GABA 
anti-reward neurons. It appears as if the mGluR5 protomer in 
A2AR-mGluR5 hetero complexes and its Gq-mediated sign-
aling in the nucleus accumbens shell can play an important 
role in activating STEP. It can participate in mediating the 
STEP activation by cocaine in parts of the ventral striatum. 
It is proposed that A2AR-mGluR5 heteroreceptor complexes 
can play a significant role through A2AR-mediated allos-
teric enhancement of Gq-mediated mGluR5 signaling in this 
complex. In view of the fact that  STEP61 can directly bind to 
mGluR5 [13], it will be of high interest to test how mGluR5 
can play a key role in the dynamic balance with STEP acti-
vation. mGluR5 appears to significantly modulate through 
phosphorylation and allosteric mechanisms the synaptic 
activity of AMPA and NMDA receptors. These actions by 
mGluR5 can involve the modulation of the dephosphoryla-
tion of these synaptic glutamate receptors by activated STEP 
associated with AMPA and NMDA receptors which can lead 
to synaptic depression in the nucleus accumbens shell.
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